Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease

Recruiting now

Conditions studied: cGVHD

In brief

The purpose of this prospective observational study is to collect data from participants who have recently had an allogenic Stem Cell Transplant(alloSCT) and are at risk of Chronic Graft Versus Host Disease(cGVHD)

Key facts

Study ID

NCT05919511

Run by

Incyte Corporation

People needed

1500

Starts

2023-08-01

Expected to finish

2027-10-15

Last updated by the study team

2026-03-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥ 18 years inclusive at the time of signing the ICF
• Allogeneic SCT 90 to 180 days prior to enrollment
• Able to comprehend and willing to provide informed consent
• Willing and able to complete participant-assessment questionnaires either alone or with minimal assistance from a caregiver and/or trained site personnel

You may not qualify if…

• There are no exclusion criteria for this study

Where it is running

• Medical College of Wisconsin — Milwaukee, Wisconsin, United States (enrolling)
• Mayo Clinic Arizona — Phoenix, Arizona, United States (enrolling)
• City of Hope — Duarte, California, United States (enrolling)
• USC Norris Comprehensive Cancer Center — Los Angeles, California, United States (enrolling)
• University of Colorado — Aurora, Colorado, United States (enrolling)
• Mayo Clinic Jacksonville — Jacksonville, Florida, United States (enrolling)
• AdventHealth Orlando — Orlando, Florida, United States (enrolling)
• Moffit Cancer Center — Orlando, Florida, United States (enrolling)
• Emory University — Atlanta, Georgia, United States (enrolling)
• Georgia Cancer Center — Augusta, Georgia, United States (enrolling)
• Northwestern University — Chicago, Illinois, United States (enrolling)
• Rush University Medical Group — Chicago, Illinois, United States (enrolling)
• The University of Chicago — Chicago, Illinois, United States (enrolling)
• Loyola University Medical Center — Maywood, Illinois, United States (enrolling)
• The University of Kansas Clinical Research Center — Fairway, Kansas, United States (enrolling)
• University of Alabama Birmingham — Birmingham, Alabama, United States (enrolling)
• University of Maryland Medical Center — Baltimore, Maryland, United States (enrolling)
• Massachusetts Cancer Research Center — Boston, Massachusetts, United States (enrolling)
• Corewell Health — Grand Rapids, Michigan, United States (enrolling)
• Mayo Clinic Rochester — Rochester, Minnesota, United States (enrolling)
• Rutgers Cancer Institute of New Jersey — New Brunswick, New Jersey, United States (enrolling)
• Memorial Sloan Kettering Cancer Center — New York, New York, United States (enrolling)
• University of North Carolina at Chapel Hill — Chapel Hill, North Carolina, United States (enrolling)
• Levine Cancer Institute — Charlotte, North Carolina, United States (enrolling)
• The Ohio State University — Columbus, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.